Search Results - "Drayton, Ross"

Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11 by DRAYTON, Ross M, DUDZIEC, Ewa, PETER, Stefan, BERTZ, Simone, HARTMANN, Arndt, BRYANT, Helen E, CATTO, James WF

“…Resistance to cisplatin-based chemotherapy is a major obstacle to bladder cancer treatment. We aimed to identify microRNAs (miRNA) that are dysregulated in…”
Get full text

The role of microRNA in the response to cisplatin treatment by Drayton, Ross M

“…Resistance to the cytotoxic effects of cisplatin can be mediated through changes in a wide variety of cellular processes and signalling pathways. The discovery…”
Get more information

Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells by Fathers, Catherine, Drayton, Ross M., Solovieva, Svetlana, Bryant, Helen E.

“…Poly(ADP-ribose) glycohydrolase (PARG), removes poly(ADP-ribose) subunits from proteins that have previously been modified by poly(ADP-ribose) polymerse. This…”
Get full text

Identification of differentially expressed long noncoding RNAs in bladder cancer by Peter, Stefan, Borkowska, Edyta, Drayton, Ross M, Rakhit, Callum P, Noon, Aidan, Chen, Wei, Catto, James Wf

“…Loss of epigenetic gene regulation through altered long noncoding RNA (lncRNA) expression seems important in human cancer. LncRNAs have diagnostic and…”
Get full text

Molecular mechanisms of cisplatin resistance in bladder cancer by Drayton, Ross M, Catto, James WF

“…Metastatic disease is the most common mechanism of death in patients with advanced bladder cancer. As for most solid tumors, chemotherapy remains the only…”
Get full text

MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer by Drayton, Ross M, Peter, Stefan, Myers, Katie, Miah, Saiful, Dudziec, Ewa, Bryant, Helen E, Catto, James W F

“…Urothelial cell carcinoma of the bladder (UCC) is a common disease often characterized by FGFR3 dysregulation. Whilst upregulation of this oncogene occurs most…”
Get full text

The Fanconi anemia pathway is downregulated upon macrophage differentiation through two distinct mechanisms by Lu, Wei-Ting, Lemonidis, Kimon, Drayton, Ross M., Nouspikel, Thierry

“…The Fanconi anemia (FA) pathway is a DNA-damage inducible pathway critical for genomic stability. FA patients typically display high cancer susceptibility and…”
Get full text

Identification and diagnostic performance of a small RNA within the PCA3 and BMCC1 gene locus that potentially targets mRNA by Drayton, Ross M, Rehman, Ishtiaq, Clarke, Raymond, Zhao, Zhongming, Pang, Karl, Miah, Saiful, Stoehr, Robert, Hartmann, Arndt, Blizard, Sheila, Lavin, Martin, Bryant, Helen E, Martens-Uzunova, Elena S, Jenster, Guido, Hamdy, Freddie C, Gardiner, Robert A, Catto, James W F

“…PCA3 is a long noncoding RNA (lncRNA) with unknown function, upregulated in prostate cancer. LncRNAs may be processed into smaller active species. We…”
Get full text

Toxicogenomics of Non-viral Vectors for Gene Therapy: A Microarray Study of Lipofectin- and Oligofectamine-induced Gene Expression Changes in Human Epithelial Cells by Omidi, Yadollah, Hollins, Andrew J., Benboubetra, Mustapha, Drayton, Ross, Benter, Ibrahim F., Akhtar, Saghir

“…Of the non-viral vectors, cationic lipid (CL) formulations are the most widely studied for the delivery of genes, antisense oligonucleotides and gene silencing…”
Get full text

Reduced expression of microRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11 by Drayton, Ross M, Dudziec, Ewa, Peter, Stefan, Bertz, Simone, Hartmann, Arndt, Bryant, Helen E, Catto, James WF

Get full text

Abstract A10: MicroRNA 27a is downreguated in cisplatin resistant bladder cancer cells, and contributes to resistance through the targeting of xCT, a cystine transporter involved with glutathione production by Drayton, Ross M., Dudziec, Ewa, Catto, James W.F., Bryant, Helen E.

“…Abstract Cisplatin resistance represents a serious obstacle to the chemotherapeutic treatment of many tumors. The purpose of this study was to create a cell…”
Get full text

Drug sensitivity and apoptosis in tamoxifen resistant breast cancer by Drayton, Ross

“…Tamoxifen has long been used in the treatment of hormone responsive breast cancer. However, tumours frequently develop resistance within 2-5 years of…”
Get full text